Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Incyte Corporation - Common Stock
(NQ:
INCY
)
123.20
-1.62 (-1.30%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 29, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,712,218
Open
123.67
Bid (Size)
121.57 (100)
Ask (Size)
123.25 (100)
Prev. Close
124.82
Today's Range
121.89 - 125.47
52wk Range
82.52 - 132.60
Shares Outstanding
222,430,635
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Mirum Pharmaceuticals and Incyte Announce U.S. FDA Approval of Atebrioz™ (zilurgisertib) for Adult and Pediatric Patients with Fibrodysplasia Ossificans Progressiva
September 25, 2026
From
Mirum Pharmaceuticals, Inc. and Incyte
Via
Business Wire
Discover the top S&P500 movers in Tuesday's pre-market session.
↗
September 22, 2026
Via
Chartmill
Performance
YTD
+21.5%
+21.5%
1 Month
-0.0%
-0.0%
3 Month
+7.4%
+7.4%
6 Month
+36.4%
+36.4%
1 Year
+46.9%
+46.9%
More News
Read More
Incyte Data at the European Academy of Dermatology and Venereology (EADV) Congress Underscore the Breadth of Incyte’s Inflammation and Autoimmunity Portfolio
September 22, 2026
From
Incyte
Via
Business Wire
Incyte Maps Post-JAKAFI Growth With Pipeline Push and $4B Sales Target
↗
September 19, 2026
Via
MarketBeat
Incyte (NASDAQ:INCY) Combines Minervini Trend Template Strength With High-Growth Momentum
↗
September 18, 2026
Via
Chartmill
Incyte (NASDAQ:INCY) Combines High Growth Momentum with a Breakout Setup
↗
September 08, 2026
Via
Chartmill
Incyte (NASDAQ:INCY) Passes Minervini Trend and High-Growth Screens, But Setup Demands Patience
↗
August 27, 2026
Via
Chartmill
Incyte (NASDAQ:INCY) Combines High Growth Momentum with a Breakout Setup
↗
August 17, 2026
Via
Chartmill
3 Growth Stocks to Add to Your Roster
September 17, 2026
Via
StockStory
Topics
Economy
1 Cash-Heavy Stock for Long-Term Investors and 2 We Ignore
September 16, 2026
Via
StockStory
Topics
Credit Cards
Incyte (INCY): 3 Reasons We Love This Stock
September 14, 2026
Via
StockStory
Topics
Artificial Intelligence
Stocks
Here's How Much $1000 Invested In Incyte 20 Years Ago Would Be Worth Today
↗
September 11, 2026
Via
Benzinga
Incyte (NASDAQ:INCY): High Growth Stock Slides on Q2 Beat but Steep Guidance Cut
↗
July 28, 2026
Via
Chartmill
2 Cash-Producing Stocks with Promising Prospects and 1 We Brush Off
September 11, 2026
Via
StockStory
3 Market-Beating Stocks with Competitive Advantages
September 09, 2026
Via
StockStory
Topics
Artificial Intelligence
Intellectual Property
2 Profitable Stocks with Impressive Fundamentals and 1 We Brush Off
September 04, 2026
Via
StockStory
Incyte to Present at Upcoming Investor Conferences
September 01, 2026
From
Incyte
Via
Business Wire
Here’s How Much You Would Have Made Owning Incyte Stock In The Last 20 Years
↗
August 20, 2026
Via
Benzinga
Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 07, 2026
From
Incyte Corporation
Via
Business Wire
1 Unpopular Stock That Deserves Some Love and 2 Facing Headwinds
July 31, 2026
Via
StockStory
Topics
Supply Chain
Opzelura® (ruxolitinib) Cream Becomes First Steroid-Free Topical JAK Inhibitor Approved in the European Union for Adults with Moderate Atopic Dermatitis
July 29, 2026
From
Incyte
Via
Business Wire
Exploring the top movers within the S&P500 index during today's session.
↗
July 28, 2026
Via
Chartmill
Curious about which S&P500 stocks are generating unusual volume on Tuesday? Find out below.
↗
July 28, 2026
Via
Chartmill
Incyte Q2 Earnings Call Highlights
↗
July 28, 2026
Via
MarketBeat
Topics
Earnings
Incyte (NASDAQ:INCY) Posts Better-Than-Expected Sales In Q2 CY2026 But Full-Year Sales Guidance Misses Expectations Significantly
July 28, 2026
Via
StockStory
Frequently Asked Questions
Is Incyte Corporation - Common Stock publicly traded?
Yes, Incyte Corporation - Common Stock is publicly traded.
What exchange does Incyte Corporation - Common Stock trade on?
Incyte Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Incyte Corporation - Common Stock?
The ticker symbol for Incyte Corporation - Common Stock is INCY on the Nasdaq Stock Market
What is the current price of Incyte Corporation - Common Stock?
The current price of Incyte Corporation - Common Stock is 123.20
When was Incyte Corporation - Common Stock last traded?
The last trade of Incyte Corporation - Common Stock was at 09/29/26 04:00 PM ET
What is the market capitalization of Incyte Corporation - Common Stock?
The market capitalization of Incyte Corporation - Common Stock is 27.40B
How many shares of Incyte Corporation - Common Stock are outstanding?
Incyte Corporation - Common Stock has 27B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.